Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/bjd.14203 | DOI Listing |
Z Rheumatol
August 2024
Rheumazentrum Ruhrgebiet, Herne, Deutschland.
Background: The treatment of axial spondylarthritis (axSpA) includes pharmacological treatment measures (PTM) and nonpharmacological treatment measures (NPTM) as well as supporting resources, such as rehabilitation services (RS) and membership in patient support groups (PSG). Nevertheless, there are significant participation restrictions in patients with axSpA in Germany.
Objective: Investigation of functional deficits, participation restrictions and utilization of PTM, NPTM, RS and PSG membership in patients with axSpA.
Br J Dermatol
April 2016
Novartis Pharma GmbH, Nuremberg, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!